PRVA News and Press, Privia Health Group Inc. From 01/17/23

Physician platform Privia Health Group ( NASDAQ: PRVA ) traded higher on Tuesday after Piper Sandler issued bullish views on the company citing newly released data from the Centers for Medicare & Medicaid Services (CMS) on Accountable Care Organizations ((ACOs)). The analysts led ...

ARLINGTON, Va., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present and participate in a Q&A session at the 41 st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 beginning at 6:00 pm ET / ...

ARLINGTON, Va., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to participate in a "fireside chat" Q&A session at the 34 th Annual Piper Sandler Healthcare Conference on Wednesday, November 30, 2022 beginning...

Privia Health ( NASDAQ: PRVA ) has priced its previously announced underwritten public offering of 5M shares of common stock by certain selling stockholders at a public offering price of $23.50/share. Underwriters are granted a 30-day option to purchase up to an additi...

Privia Health ( NASDAQ: PRVA ) on Tuesday announced a secondary offering of 5M shares of common stock of the company by certain selling stockholders. Selling stockholders intend to grant underwriters of the secondary offering a 30-day option to purchase up to an additional...

ARLINGTON, Va., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Jeff Butler has resigned from the Company’s Board of Directors and as a member of the Compliance Committee of the Board, effective immediately. Mr. Butler’s resignat...

Privia Health Group, Inc. (PRVA) Q3 2022 Earnings Conference Call November 10, 2022 08:30 ET Company Participants Robert Borchert - Investor Relations Shawn Morris - Chief Executive Officer Parth Mehrotra - President and Chief Operating Officer David Mountcas...

Privia Health Group press release ( NASDAQ: PRVA ): Q3 Non-GAAP EPS of $0.13 beats by $0.01 . Revenue of $342.9M (+36.3% Y/Y) beats by $24.09M . For FY2022, the company expects Adjusted EBITDA between $59M to $61M. For further details see: Privia Heal...

Results and outlook reflect strong year-to-date performance and business momentum Implemented Providers +27.2% compared to 3Q’21 Practice Collections +52.4% compared to 3Q’21 Shared savings of ~$100 million achieved through Medicare Shared Savings...

Summary The US healthcare industry faces several challenges that Privia Health Group can resolve. The Privia Platform is the backbone of the company. This platform is built with a physician-first mindset. I believe PRVA is undervalued as of today. Thesis highlight ...